ADVERTISEMENT
ADVERTISEMENT
HaystackAnalytics Ushers in the Most Advanced Technology to Bridge the Diagnostic Gap in Infectious Diseases
The company celebrates the Indian scientists and institutions building diagnostic capability at home, with the potential to address challenges shared globally
-
Response Feature - Tue, 18, Aug 2026
- 10:53 EDT
- 30
HaystackAnalytics founders / Handout
Confounding clinical presentation, complex disease pathways, a disparate healthcare ecosystem and fragmented diagnostics pose some of healthcare’s most difficult diagnostic challenges. These are not unique to India but plague the world with devastating consequences. Poor access to near point of care advanced solutions in infectious diseases, delays associated in a hub and spoke model of testing through centralised laboratories and complexity of cascading diagnostics in infectious diseases continue to challenge health systems across the world.
HaystackAnalytics identified a critical gap in this landscape - advanced clinical-grade diagnostics existed but were inaccessible.
Through its expanding network of Genomic Centres of Excellence (GCEs), the company has demonstrated the power of distributive genomics in infectious disease diagnostics in India, a model where advanced clinical grade genomics based diagnostics are not confined to a handful of specialised centres, but are embedded closer to the patients, hospitals, and clinicians who need it the most.
Over the next 12 months, HaystackAnalytics plans to scale the network to 100 centres across India, thus working towards a future of rewriting the diagnostic playbook in infectious disease diagnostics.
At that scale, genomic infection diagnostics could become accessible across a far broader healthcare footprint. Hospitals that previously depended on distant specialised facilities or conventional approaches could gain access to advanced sequencing capabilities within their own diagnostic ecosystems, helping clinicians investigate complex infections closer to where patients are being treated.
“India brings together scale, diversity, and some of the most complex healthcare access challenges in the world. Our vision is to show that advanced genomic diagnostics can be made accessible across such a diverse healthcare system, and what we build here can have relevance far beyond India,” said Anirvan Chatterjee, PhD, CEO and co-founder, HaystackAnalytics.
This Independence Day, that ambition is brought to life by the people behind it. The company celebrates the Indian scientists and institutions building diagnostic capability at home, with the potential to address challenges shared globally.
HaystackAnalytics envisions a future where Indian genomics does not simply create new technology, but creates a scalable pathway for bringing quick, advanced infection diagnostics closer to patients.
(Disclaimer: The above is a sponsored post, the views expressed are those of the sponsor/author and do not represent the stand and views of New India Abroad or Indian Star LLC.)
Leave A Comment
Related
ADVERTISEMENT
ADVERTISEMENT
E Paper
Video
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login